retatrutide georgia trifluoroacetate | 2381089-83-2 What Does Retatrutide Do |

Gastrointestinal symptomsparticularly nausea, vomiting, diarrhoea, and constipationare the most frequently reported adverse effects of GLP-1 receptor agonists, occurring in 2050% of patients depending on the specific agent and dose according to clinical trials and SmPC data

They all also work very similarly in the body to make patients feel as if they are fuller for longer, making it much easier to maintain a calorie deficient diet

Its followed by the catagen or transitional phase, the telogen or resting phase and then the exogen or shedding phase

They are not large enough or long enough to catch every safety signal